Quantcast

Latest Oncologists Stories

2014-08-28 12:29:07

Free Educational Session for prostate cancer patients, their spouses and advocates. DETROIT, Aug. 28, 2014 /PRNewswire-USNewswire/ -- The Barbara Ann Karmanos Cancer Institute, in collaboration with Wayne State University School of Medicine (WSU SOM), will present the fourth annual Prostate Cancer Symposium, Latest Treatment Advancements: What you learn here could save your life, Saturday, Sept. 20, from 8 a.m. - 2:30 p.m., at the Charles H. Wright Museum of African American History...

2014-08-19 12:28:37

LOS ANGELES, Aug. 19, 2014 /PRNewswire/ -- Dr. Jack Kavanaugh DDS, MD, MBA, founder and former Chairman/CEO of ZetaRx and a physician who has dedicated his career to accelerating disruptive medical technology development, is launching a cancer therapeutic company, Novonco Therapeutics, Inc., in partnership with Dr. David Horne from The City of Hope, Dr. Larry Overman from The University of California, Irvine, and The City of Hope. Novonco, of which Dr. Kavanaugh is Chairman, builds...

2014-08-02 23:02:05

The Oncology Institute of Hope and Innovation welcomes Dr. Ping Hu to their team of specialists. Downey, CA (PRWEB) August 02, 2014 Dr. Ping Hu is a worldly educated and trained oncologist. She received her undergraduate degree in Medicine from the Capital Medical University in Beijing, China and her Masters of Science in General and Medical Microbiology from the University of London. She completed her residency at the Texas Tech University Health Sciences Center and finished her...

2014-08-01 16:23:45

AUSTIN, Texas, Aug. 1, 2014 /PRNewswire/ -- XBiotech has enrolled the first patient into its European Phase III study using its novel cancer drug Xilonix(TM) for the treatment of colorectal cancer. The double-blinded placebo controlled study is evaluating the use of the monoclonal antibody therapy designed to block chronic inflammation associated with malignant tumor growth. The treatment is reportedly aimed at reversing disease symptoms associated with disease progression and...

2014-07-30 08:33:32

LOS ANGELES, July 30, 2014 /PRNewswire/ -- Skyline Urology Chief Medical Officer Dr. Richard David has been named Clinical Professor of Urology, Voluntary at the David Geffen School of Medicine at UCLA. A nationally known expert in urologic cancers, Dr. David has served on the UCLA clinical faculty for 24 years. He sees patients at his Skyline Urology office in Sherman Oaks. "I have truly valued my time on the UCLA Clinical faculty. I was taught to always put the patient first. I...

2014-07-28 12:28:42

Largest private donation to date puts ambitious campaign over $400 million mark in record time PORTLAND, Ore., July 28, 2014 /PRNewswire/ -- Oregon Health & Science University's Knight Cancer Institute has received a $100 million gift to fuel its ambitious vision to stop cancer in its tracks. http://photos.prnewswire.com/prnvar/20140725/130463 A donor, who wishes to remain unnamed, pledged the funds as part of OHSU's unprecedented $1 billion campaign to support the Knight...

2014-07-17 23:08:44

Dr. Mark Soloway, who has been appointed Chief of Urologic Oncology at Memorial Cancer Institute, will lead a new division focused on the care of bladder, prostate and kidney cancers, while also establishing a research program. Hollywood, Fla. (PRWEB) July 17, 2014 Mark Soloway, MD, an internationally recognized leader in urologic oncology, has joined the Memorial Cancer Institute and the Memorial Physician Group. Dr. Soloway, who has been appointed Chief of Urologic Oncology, will lead a...

2014-07-11 08:24:23

Company Provides Widest Variety of Actionable Next-Gen Cancer Profiles FT. MYERS, Fla., July 11, 2014 /PRNewswire/ -- NeoGenomics, Inc. (NASDAQ: NEO), a leading provider of cancer-focused genetic and molecular testing services, announced today it has launched 23 new and innovative NeoTYPE(TM) Cancer Profiles based on next-generation sequencing (NGS). These new advanced cancer-profiling tools offer oncologists and pathologists a more targeted and comprehensive ability to tailor...

2014-07-07 23:02:25

Allegheny Health Network, Pittsburgh, and Johns Hopkins Medicine today announced that a definitive agreement has been signed by the two organizations that establishes a five-year formal collaboration between Allegheny and the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins for research, medical education and clinical services. Pittsburgh, PA (PRWEB) July 07, 2014 Officials at Allegheny Health Network and Johns Hopkins Medicine today announced that a definitive agreement has...

2014-07-01 08:29:44

Former Genentech executive to lead Moderna's first venture company, focused exclusively in novel biology for oncology drug development CAMBRIDGE, Mass., July 1, 2014 /PRNewswire/ -- Moderna Therapeutics, the pioneer in developing messenger RNA (mRNA) Therapeutics(TM), a revolutionary treatment modality to enable the in vivo production of therapeutic proteins, announced today that Stephen Kelsey, M.D., will become president of Onkaido Therapeutics, Moderna's oncology drug development...


Word of the Day
bodacious
  • Remarkable; prodigious.
  • Audacious; gutsy.
  • Completely; extremely.
  • Audaciously; boldly.
  • Impressively great in size; enormous; extraordinary.
This word is probably from the dialectal 'boldacious,' a blend of 'bold' and 'audacious.'
Related